Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias
Clinical trial NCT02041325 · COMPLETED
Trial details
- NCT number
- NCT02041325
- Sponsor
- Boston VA Research Institute, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2011-01-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.